PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions

Aura Biosciences, Inc. (AURA)

Equity · Currency in USD · Last updated Dec 6, 2023
SummaryFinancials

Company Info

ISINUS05153U1079
CUSIP05153U107
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap$403.93M
EPS-$1.95
EBITDA (TTM)-$76.53M
Year Range$5.99 - $13.50
Target Price$25.00
Short %6.31%
Short Ratio8.37

Share Price Chart


Loading data...

Performance

The chart shows the growth of an initial investment of $10,000 in Aura Biosciences, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%10.00%JulyAugustSeptemberOctoberNovemberDecember
-34.38%
7.03%
AURA (Aura Biosciences, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with AURA

Aura Biosciences, Inc.

Popular comparisons: AURA vs. VOO

Return

Aura Biosciences, Inc. had a return of -19.81% year-to-date (YTD) and -31.99% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date-19.81%18.95%
1 month-29.72%4.79%
6 months-36.83%6.61%
1 year-31.99%14.21%
5 years (annualized)N/A11.15%
10 years (annualized)N/A9.75%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202325.22%9.10%-3.64%-12.77%-13.58%-9.03%-1.72%

Risk-Adjusted Performance

This table presents a comparison of risk-adjusted performance metrics for Aura Biosciences, Inc. (AURA) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
AURA
Aura Biosciences, Inc.
-0.56
^GSPC
S&P 500
0.88

Sharpe Ratio

The current Aura Biosciences, Inc. Sharpe ratio is -0.56. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.00JulyAugustSeptemberOctoberNovemberDecember
-0.56
0.88
AURA (Aura Biosciences, Inc.)
Benchmark (^GSPC)

Dividend History


Aura Biosciences, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-66.17%
-4.78%
AURA (Aura Biosciences, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Aura Biosciences, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Aura Biosciences, Inc. was 71.80%, occurring on Nov 9, 2023. The portfolio has not yet recovered.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-71.8%Nov 17, 2021498Nov 9, 2023
-15.46%Nov 8, 20211Nov 8, 20215Nov 15, 20216

Volatility Chart

The current Aura Biosciences, Inc. volatility is 42.89%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%JulyAugustSeptemberOctoberNovemberDecember
42.89%
2.85%
AURA (Aura Biosciences, Inc.)
Benchmark (^GSPC)